The impact of host metabolic factors on treatment outcome in chronic hepatitis C.

Gastroenterology Research and Practice
Savvidou SavvoulaGoulis John

Abstract

Background. Recent data suggest that chronic hepatitis C has to be considered a metabolic disease further to a viral infection. The aim of this study was to elaborate on the complex interactions between hepatitis C virus, host metabolic factors, and treatment response. Methods. Demographic, virological, and histological data from 356 consecutive patients were analyzed retrospectively. Hepatic steatosis, obesity, and insulin resistance were examined in relation to their impact on treatment outcome. Comparison between genotype 1 and 3 patients was performed to identify differences in the determinants of hepatic steatosis. Results. Histological evidence of hepatic steatosis was found in 113 patients, distributed in 20.3%, 9.0%, and 2.5% for grades I, II, and III, respectively. Hepatic steatosis was associated with past alcohol abuse (P = 0.003) and histological evidence of advanced fibrosis (P < 0.001). Older age (OR 2.51, P = 0.002), genotype (OR 3.28, P < 0.001), cirrhosis (OR 4.23, P = 0.005), and hepatic steatosis (OR 2.48, P = 0.001) were independent predictors for nonresponse. Correlations of hepatic steatosis with alcohol, insulin resistance, and fibrosis stage were found similar for both genotypes 1 and 3. Conclusions. Hos...Continue Reading

References

Aug 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P Bedossa, T Poynard
Jul 1, 1997·The Journal of General Virology·K MoriyaK Koike
Sep 14, 1999·The American Journal of Gastroenterology·E M BruntB R Bacon
Dec 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E M Brunt
Jul 25, 2000·Journal of Hepatology·L Rubbia-BrandtF Negro
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L E AdinolfiG Ruggiero
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dinesh KumarJacob George
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick MarcellinNathalie Boyer
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thierry PoynardJanice Albrecht
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brian L BresslerJenny Heathcote
Sep 23, 2003·The American Journal of Gastroenterology·Arun J SanyalA Scott Mills
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B StraderUNKNOWN American Association for the Study of Liver Diseases
May 5, 2004·Journal of Hepatology·Francesco Negro
Jan 28, 2005·European Journal of Gastroenterology & Hepatology·Konstantinos C ThomopoulosChrysoula Labropoulou-Karatza
Mar 4, 2005·The American Journal of Gastroenterology·Laurent CasteraJean-Michel Pawlotsky
Jun 14, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen A HarrisonBruce R Bacon
Jan 27, 2006·Journal of Viral Hepatitis·A LonardoG Ruggiero
Mar 15, 2006·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Reiko YaginumaNobuhiro Sato
Jul 29, 2006·Journal of Gastroenterology and Hepatology·Carla A L MatosMaria L G Ferraz
Oct 13, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·M SoresiG Montalto
Jun 20, 2007·Journal of Viral Hepatitis·D RoulotUNKNOWN Observational VHC4 Study Group
Jul 19, 2008·World Journal of Gastroenterology : WJG·Abdel-Rahman El-Zayadi
Feb 24, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Francesco Negro, Arun J Sanyal
Jul 25, 2009·Journal of Medical Virology·Hesham El MakhzangyMostafa K Mohamed
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Asma Siddique, Kris Kowdley

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.